Annual CFO
-$17.12 M
-$3.44 M-25.13%
01 December 2023
Summary:
COSCIENS Biopharma annual cash flow from operations is currently -$17.12 million, with the most recent change of -$3.44 million (-25.13%) on 01 December 2023. During the last 3 years, it has fallen by -$8.54 million (-99.49%).CSCI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$7.78 M
-$6.39 M-458.27%
01 September 2024
Summary:
COSCIENS Biopharma quarterly cash flow from operations is currently -$7.78 million, with the most recent change of -$6.39 million (-458.27%) on 01 September 2024. Over the past year, it has dropped by -$6.54 million (-530.39%).CSCI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$12.80 M
-$7.92 M-162.41%
01 September 2024
Summary:
COSCIENS Biopharma TTM cash flow from operations is currently -$12.80 million, with the most recent change of -$7.92 million (-162.41%) on 01 September 2024. Over the past year, it has dropped by -$10.07 million (-368.80%).CSCI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -530.4% | -368.8% |
| 3 y3 years | -99.5% | -1570.2% | -565.0% |
| 5 y5 years | -59.6% | -2313.6% | -1995.9% |
CSCI Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -232.3% | -483.1% | -355.6% |
COSCIENS Biopharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.78 M(+458.3%) | -$12.80 M(+162.4%) |
| June 2024 | - | -$1.39 M(-41.9%) | -$4.88 M(+13.5%) |
| Mar 2024 | - | -$2.40 M(+94.2%) | -$4.30 M(+57.4%) |
| Dec 2023 | -$17.12 M(+25.1%) | -$1.23 M(-951.0%) | -$2.73 M(+272.1%) |
| Sept 2023 | - | $145.00 K(-117.8%) | -$734.00 K(-516.3%) |
| June 2023 | - | -$813.00 K(-1.9%) | $176.30 K(-94.2%) |
| Mar 2023 | - | -$829.00 K(-208.7%) | $3.02 M(-38.2%) |
| Dec 2022 | -$13.68 M(+59.4%) | $763.00 K(-27.7%) | $4.89 M(+5.0%) |
| Sept 2022 | - | $1.06 M(-48.0%) | $4.66 M(+20.5%) |
| June 2022 | - | $2.03 M(+95.0%) | $3.86 M(+8.7%) |
| Mar 2022 | - | $1.04 M(+96.8%) | $3.55 M(+29.0%) |
| Dec 2021 | -$8.58 M(+107.8%) | $529.10 K(+102.2%) | $2.75 M(+28.2%) |
| Sept 2021 | - | $261.70 K(-84.8%) | $2.15 M(-37.9%) |
| June 2021 | - | $1.72 M(+612.3%) | $3.46 M(+2.9%) |
| Mar 2021 | - | $241.60 K(-415.8%) | $3.36 M(-3.8%) |
| Dec 2020 | -$4.13 M(-61.5%) | -$76.50 K(-104.9%) | $3.49 M(+7.6%) |
| Sept 2020 | - | $1.57 M(-3.1%) | $3.25 M(+60.5%) |
| June 2020 | - | $1.62 M(+332.9%) | $2.02 M(+161.0%) |
| Mar 2020 | - | $374.70 K(-216.3%) | $775.00 K(+14.8%) |
| Dec 2019 | -$10.72 M(-257.1%) | -$322.30 K(-192.6%) | $675.30 K(-322.6%) |
| Sept 2019 | - | $348.10 K(-7.0%) | -$303.40 K(-74.7%) |
| June 2019 | - | $374.50 K(+36.2%) | -$1.20 M(-23.7%) |
| Mar 2019 | - | $275.00 K(-121.1%) | -$1.57 M(+0.7%) |
| Dec 2018 | $6.83 M(-129.8%) | -$1.30 M(+138.0%) | -$1.56 M(-1267.0%) |
| Sept 2018 | - | -$546.60 K(<-9900.0%) | $133.50 K(-91.5%) |
| June 2018 | - | $3300.00(-98.8%) | $1.57 M(-6.1%) |
| Mar 2018 | - | $286.30 K(-26.7%) | $1.68 M(+34.0%) |
| Dec 2017 | -$22.91 M(-21.0%) | $390.50 K(-56.3%) | $1.25 M(-8.7%) |
| Sept 2017 | - | $894.30 K(+746.1%) | $1.37 M(+10.8%) |
| June 2017 | - | $105.70 K(-175.7%) | $1.24 M(-29.1%) |
| Mar 2017 | - | -$139.60 K(-127.4%) | $1.74 M(-52.0%) |
| Dec 2016 | -$29.01 M(-14.3%) | $509.70 K(-33.0%) | $3.63 M(-25.0%) |
| Sept 2016 | - | $760.40 K(+24.0%) | $4.84 M(-3.3%) |
| June 2016 | - | $613.10 K(-65.0%) | $5.01 M(+5.3%) |
| Mar 2016 | - | $1.75 M(+1.9%) | $4.76 M(+65.8%) |
| Dec 2015 | -$33.84 M(+8.9%) | $1.72 M(+85.6%) | $2.87 M(+72.5%) |
| Sept 2015 | - | $925.90 K(+156.3%) | $1.66 M(+38.3%) |
| June 2015 | - | $361.20 K(-365.0%) | $1.20 M(-15.1%) |
| Mar 2015 | - | -$136.30 K(-126.6%) | $1.42 M(-23.0%) |
| Dec 2014 | -$31.08 M(+55.5%) | $513.10 K(+10.4%) | $1.84 M(+23.4%) |
| Sept 2014 | - | $464.70 K(-19.1%) | $1.49 M(+22.8%) |
| June 2014 | - | $574.60 K(+100.4%) | $1.21 M(+62.9%) |
| Mar 2014 | - | $286.70 K(+74.9%) | $744.80 K(+61.8%) |
| Dec 2013 | -$19.98 M(-35.1%) | $163.90 K(-12.9%) | $460.20 K(+877.1%) |
| Sept 2013 | - | $188.10 K(+77.3%) | $47.10 K(-30.5%) |
| June 2013 | - | $106.10 K(+4952.4%) | $67.80 K(-184.9%) |
| Mar 2013 | - | $2100.00(-100.8%) | -$79.90 K(-32.2%) |
| Dec 2012 | -$30.82 M(+17.4%) | -$249.20 K(-219.3%) | -$117.90 K(-127.0%) |
| Sept 2012 | - | $208.80 K(-601.9%) | $437.20 K(+75.9%) |
| June 2012 | - | -$41.60 K(+15.9%) | $248.50 K(-39.4%) |
| Mar 2012 | - | -$35.90 K(-111.7%) | $409.80 K(-48.2%) |
| Dec 2011 | -$26.24 M(-17.2%) | $305.90 K(+1421.9%) | $791.60 K(+43.8%) |
| Sept 2011 | - | $20.10 K(-83.2%) | $550.60 K(-45.3%) |
| June 2011 | - | $119.70 K(-65.4%) | $1.01 M(+23.6%) |
| Mar 2011 | - | $345.90 K(+433.0%) | $814.50 K(+69.9%) |
| Dec 2010 | -$31.71 M | $64.90 K(-86.4%) | $479.50 K(+788.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $475.90 K(-759.1%) | $54.00 K(-110.0%) |
| June 2010 | - | -$72.20 K(-762.4%) | -$539.50 K(-33.9%) |
| Mar 2010 | - | $10.90 K(-103.0%) | -$815.80 K(-11.9%) |
| Dec 2009 | -$24.14 M(+1797.6%) | -$360.60 K(+206.6%) | -$925.50 K(+49.2%) |
| Sept 2009 | - | -$117.60 K(-66.3%) | -$620.40 K(+122.3%) |
| June 2009 | - | -$348.50 K(+252.7%) | -$279.10 K(-3.5%) |
| Mar 2009 | - | -$98.80 K(+78.0%) | -$289.10 K(-68.2%) |
| Dec 2008 | -$1.27 M(-95.0%) | -$55.50 K(-124.8%) | -$909.40 K(-47.4%) |
| Sept 2008 | - | $223.70 K(-162.4%) | -$1.73 M(-17.1%) |
| June 2008 | - | -$358.50 K(-50.1%) | -$2.08 M(+17.7%) |
| Mar 2008 | - | -$719.10 K(-17.8%) | -$1.77 M(+61.5%) |
| Dec 2007 | -$25.53 M(-420.8%) | -$874.70 K(+560.6%) | -$1.10 M(+357.8%) |
| Sept 2007 | - | -$132.40 K(+192.3%) | -$239.60 K(-44.0%) |
| June 2007 | - | -$45.30 K(+1.8%) | -$427.50 K(+276.7%) |
| Mar 2007 | - | -$44.50 K(+155.7%) | -$113.50 K(-180.7%) |
| Dec 2006 | $7.96 M(-38.5%) | -$17.40 K(-94.6%) | $140.60 K(+545.0%) |
| Sept 2006 | - | -$320.30 K(-219.2%) | $21.80 K(-92.7%) |
| June 2006 | - | $268.70 K(+28.2%) | $300.60 K(+4910.0%) |
| Mar 2006 | - | $209.60 K(-253.9%) | $6000.00(-101.6%) |
| Dec 2005 | $12.93 M(+31.4%) | -$136.20 K(+228.2%) | -$369.00 K(+12.1%) |
| Sept 2005 | - | -$41.50 K(+60.2%) | -$329.10 K(+62.0%) |
| June 2005 | - | -$25.90 K(-84.3%) | -$203.10 K(-0.9%) |
| Mar 2005 | - | -$165.40 K(+71.8%) | -$204.90 K(+166.8%) |
| Dec 2004 | $9.84 M(-196.0%) | -$96.30 K(-214.0%) | -$76.80 K(-27.5%) |
| Sept 2004 | - | $84.50 K(-405.1%) | -$106.00 K(-35.7%) |
| June 2004 | - | -$27.70 K(-25.7%) | -$164.80 K(+67.8%) |
| Mar 2004 | - | -$37.30 K(-70.3%) | -$98.20 K(-280.2%) |
| Dec 2003 | -$10.25 M(-26.3%) | -$125.50 K(-588.3%) | $54.50 K(-58.6%) |
| Sept 2003 | - | $25.70 K(-33.9%) | $131.50 K(+3.1%) |
| June 2003 | - | $38.90 K(-66.3%) | $127.60 K(+62.3%) |
| Mar 2003 | - | $115.40 K(-337.9%) | $78.60 K(-236.0%) |
| Dec 2002 | -$13.91 M(+40.1%) | -$48.50 K(-322.5%) | -$57.80 K(+51.3%) |
| Sept 2002 | - | $21.80 K(-315.8%) | -$38.20 K(+55.9%) |
| June 2002 | - | -$10.10 K(-51.9%) | -$24.50 K(-89.7%) |
| Mar 2002 | - | -$21.00 K(-27.3%) | -$237.00 K(-48.2%) |
| Dec 2001 | -$9.93 M(+141.6%) | -$28.90 K(-181.4%) | -$457.40 K(-2.5%) |
| Sept 2001 | - | $35.50 K(-115.9%) | -$469.30 K(-17.0%) |
| June 2001 | - | -$222.60 K(-7.8%) | -$565.40 K(-7.3%) |
| Mar 2001 | - | -$241.40 K(+491.7%) | -$610.20 K(+20.5%) |
| Dec 2000 | -$4.11 M(+135.8%) | -$40.80 K(-32.7%) | -$506.50 K(-5.6%) |
| Sept 2000 | - | -$60.60 K(-77.3%) | -$536.60 K(-1.4%) |
| June 2000 | - | -$267.40 K(+94.2%) | -$544.40 K(+95.4%) |
| Mar 2000 | - | -$137.70 K(+94.2%) | -$278.60 K(+34.5%) |
| Dec 1999 | -$1.74 M(+21.9%) | -$70.90 K(+3.7%) | -$207.20 K(-64.4%) |
| Sept 1999 | - | -$68.40 K(+4175.0%) | -$581.90 K(-60.9%) |
| June 1999 | - | -$1600.00(-97.6%) | -$1.49 M(+0.6%) |
| Mar 1999 | - | -$66.30 K(-85.1%) | -$1.48 M(-8.9%) |
| Dec 1998 | -$1.43 M(-24.2%) | -$445.60 K(-54.3%) | -$1.62 M(+8.3%) |
| Sept 1998 | - | -$975.00 K(<-9900.0%) | -$1.50 M(+102.4%) |
| June 1998 | - | $7100.00(-103.4%) | -$741.30 K(-54.1%) |
| Mar 1998 | - | -$211.30 K(-34.3%) | -$1.62 M(-48.6%) |
| Dec 1997 | -$1.89 M(+761.9%) | -$321.40 K(+49.0%) | -$3.14 M(+11.4%) |
| Sept 1997 | - | -$215.70 K(-75.2%) | -$2.82 M(+8.3%) |
| June 1997 | - | -$868.30 K(-50.1%) | -$2.61 M(+49.9%) |
| Mar 1997 | - | -$1.74 M | -$1.74 M |
| Dec 1996 | -$218.90 K | - | - |
FAQ
- What is COSCIENS Biopharma annual cash flow from operations?
- What is the all time high annual CFO for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly CFO year-on-year change?
- What is COSCIENS Biopharma TTM cash flow from operations?
- What is the all time high TTM CFO for COSCIENS Biopharma?
- What is COSCIENS Biopharma TTM CFO year-on-year change?
What is COSCIENS Biopharma annual cash flow from operations?
The current annual CFO of CSCI is -$17.12 M
What is the all time high annual CFO for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual cash flow from operations is $12.93 M
What is COSCIENS Biopharma quarterly cash flow from operations?
The current quarterly CFO of CSCI is -$7.78 M
What is the all time high quarterly CFO for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly cash flow from operations is $2.03 M
What is COSCIENS Biopharma quarterly CFO year-on-year change?
Over the past year, CSCI quarterly cash flow from operations has changed by -$6.54 M (-530.39%)
What is COSCIENS Biopharma TTM cash flow from operations?
The current TTM CFO of CSCI is -$12.80 M
What is the all time high TTM CFO for COSCIENS Biopharma?
COSCIENS Biopharma all-time high TTM cash flow from operations is $5.01 M
What is COSCIENS Biopharma TTM CFO year-on-year change?
Over the past year, CSCI TTM cash flow from operations has changed by -$10.07 M (-368.80%)